Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.520
-0.800 (-18.52%)
At close: Apr 28, 2025, 4:00 PM
3.520
0.00 (0.00%)
Pre-market: Apr 29, 2025, 7:20 AM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $129.42 million as of April 29, 2025. Its market cap has increased by 254.58% in one year.
Market Cap
129.42M
Enterprise Value
-36.39M
1-Year Change
254.58%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since October 22, 2014, Protara Therapeutics's market cap has decreased from $140.90M to $129.42M, a decrease of -8.15%. That is a compound annual growth rate of -0.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 158.80M | 45.82% |
| Dec 31, 2024 | 108.90M | 411.27% |
| Dec 29, 2023 | 21.30M | -29.47% |
| Dec 30, 2022 | 30.20M | -60.16% |
| Dec 31, 2021 | 75.80M | -72.07% |
| Dec 31, 2020 | 271.40M | 3,292.50% |
| Dec 31, 2019 | 8.00M | -81.65% |
| Dec 31, 2018 | 43.60M | 30.15% |
| Dec 29, 2017 | 33.50M | 6.35% |
| Dec 30, 2016 | 31.50M | -87.68% |
| Dec 31, 2015 | 255.70M | 49.44% |
| Dec 31, 2014 | 171.10M | 21.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 783.94B |
| UnitedHealth Group | 381.31B |
| Johnson & Johnson | 371.04B |
| AbbVie | 333.45B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.11B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |